Cases & Deals

Takeda acquires Ariad Pharmaceuticals for $5.2 billion

Clients Takeda Pharmaceuticals U.S.A., Inc.

Jones Day advised Takeda Pharmaceuticals U.S.A., Inc. on intellectual property matters relating to its $5.2 billion acquisition of Ariad Pharmaceuticals.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.